United States · FDA National Drug Code directory
AJOVY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51759-202_4e729b85-d3b0-445d-9cba-9326b4e2291f
- Product NDC
- 51759-202
- Form
- INJECTION
- Composition / generic term
- fremanezumab-vfrm
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200329
- Source listing expiry
- 20271231
Source-listed ingredients
- FREMANEZUMAB — 225 mg/1.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CONTAINER in 1 CARTON (51759-202-10) / 1.5 mL in 1 CONTAINER · 51759-202-10
- 1 CONTAINER in 1 CARTON (51759-202-11) / 1.5 mL in 1 CONTAINER · 51759-202-11
- 3 CONTAINER in 1 CARTON (51759-202-22) / 1.5 mL in 1 CONTAINER · 51759-202-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →